
Neuropsychiatric symptoms are commonly associated with mild cognitive impairment, but does amyloid pathology play a role in this relationship?

Neuropsychiatric symptoms are commonly associated with mild cognitive impairment, but does amyloid pathology play a role in this relationship?

In addition to microcephaly, evidence suggests the Zika virus may be linked to another neurological condition, according to a report from the AAN Annual Meeting.

Understanding the relationship between neurological disorders and depression, as shown at AAN 2016, can improve patient outcomes and quality of life.

Using advanced and traditional MRIs, researchers measured the amount of white matter brain damage in living retired NFL players.

The American Academy of Neurology is holding their Annual Meeting from April 15-21, 2016 in Vancouver, British Columbia.

Is fatigue with MS related to diet? Is alcohol intake tied to lower MS disability and severity? Researchers at AAN 2015 reported on how patients are affected by what they eat and drink.

These two new drugs for Alzheimer disease, presented at AAN 2015, are too good not to review. Here, a 6-slide summary of aducanumab and encenicline studies.

PACAP38 is a potent aggravator of migraine, a new study shows. This provides several new potential therapeutic targets -- most prominently a specific PACAP receptor PAC1.

Intriguing research is helping to shape our understanding of the functional connectivity and brain structure of migraineurs.

Worse strokes are more likely to occur in patients who are resistant to aspirin. Better ways to identify those patients are needed.

Here's a handy synopsis of a “hands-on” review of the current state of monitoring disease and treatment decision making in patients with multiple sclerosis.

This new guideline could change the approach many physicians take to treating a first seizure--and could improve patients’ lives.

Highlights of the first large study to describe the characteristics of post-traumatic headache and treatment response in children are summarized here.

A novel drug-device may not only be a promising non-oral triptan acute migraine treatment, but may be more efficacious than its oral counterpart.

Can the EEG predict neurological outcomes in post-anoxic encephalopathy from out-of-hospital cardiac arrest? What effect does TIA have on stroke risk in women migraineurs? What's the relationship between MS and vitamin D levels in minority populations?

Quick, how many of the following-eslicarbazepine, ezogabine, parampanel-do you recognize? These new entries into the medical armamentarium were highlighted at the AAN 2015 Annual Meeting.


A non-psychoactive component of the marijuana plant, cannabidiol in liquid form decreased seizures by an average of 50% across multiple types of severe epilepsy.

Advances in neurology science and patient care continue to make news even before the doors to the AAN 2015 Annual Meeting officially open on Saturday. These are the top stories.

A major advance in epilepsy treatment may be found in the first direct brain responsive neurostimulator, upcoming AAN meeting will have an epilepsy focus, and other top stories.

ADHD lowers the quality of life in adults with epilepsy; epilepsy is associated with social deprivation and increased risk of venous thromboembolism: details of these recent findings in this slide show.